Hook / Thesis
Core Scientific has quietly shifted the business from pure-play self-mining to selling the scarce commodity that matters most for modern compute workloads - reliable, high-density power and purpose-built data center space. That pivot is already visible in the numbers: colocation revenue jumped to $65 million in 2025 from $24 million in 2024, and management is building toward roughly 1.5 gigawatts of leasable capacity. Investors should view Core Scientific as a growth-with-risk colocation operator, not a leveraged bitcoin bet.
My trade thesis is straightforward: buy exposure to scaled colocation optionality while keeping a hard stop for execution and capital risks. The market currently prices ambitious growth into Core Scientific - the company carries a market cap of roughly $6.8 billion and an enterprise value near $9.3 billion - but there is a plausible path to justify that multiple if leasing, contractualization and margin improvement continue.
What the company does and why the market should care
Core Scientific operates two core lines - self-mining and hosting/colocation. The hosting business is now the strategic priority: customers want dense racks, predictable power, and facilities engineered for heavy compute - attributes that are hard to replicate at scale. Power- and location-constrained AI customers are increasingly valuing turnkey capacity with long-term pricing, turning what was once a bitcoin miner advantage into a defensible colocation moat.
That shift matters because colocation brings higher revenue visibility than spot mining rewards. In 2025 colocation revenue reached $65 million versus $24 million in 2024 - a strong growth signal. At the same time Core Scientific has raised capital to fund expansion, including a $500 million, 364-day loan facility that can be expanded to $1 billion. Those dollars are earmarked to accelerate buildout of leasable capacity, a necessary investment to monetize the structural advantage of existing site access to power.
Hard numbers that support the thesis
| Metric | Value |
|---|---|
| Market cap | $6.78B |
| Enterprise value | $9.29B |
| EV / Sales | 21.1x |
| Price / Sales | 15.36x |
| EPS (trailing) | -$4.29 |
| Free cash flow (trailing) | -$957.7M |
Those valuation multiples are rich on a headline basis - EV/sales of 21.1x implies the market expects the company to convert current revenue into much larger, higher-margin revenue streams. That expectation is the reason Core Scientific's stock can trade near $21 despite negative EBITDA and deep FCF deficits: the market is effectively paying for future contracted colocation revenue and scale economics.
Recent operational and market signals
- Colocation revenue growth: $65M in 2025 vs $24M in 2024 - more than doubling year over year.
- Capital availability: a $500M 364-day facility from Morgan Stanley (with accordion to $1B) provides near-term funding to accelerate capacity buildout.
- Investor interest: institutional buys and stake increases from strategic investors (e.g., Clearline’s purchase and Covalis’ $30.29M position) show some investors are willing to back the pivot to data-center economics.
- Market mechanics: short interest remains elevated - around ~63M shares on mid-July settlements - creating a potential volatility source and liquidity dynamic to watch.
Valuation framing - why this looks expensive but defensible
On the surface Core Scientific trades at high multiples: price-to-sales of ~15.4x and EV/sales of ~21x. Those figures are not justified by trailing profitability - EPS is negative and trailing free cash flow is roughly -$958M. The valuation only makes sense if management can convert colocation into a larger, contracted revenue base with materially better margins than legacy self-mining operations.
Think of the valuation as a call option on a national-scale, power-dense colocation platform. The company aims for 1.5GW of leasable capacity; if they sign long-term contracts for a meaningful portion of that space at AI-grade densities and higher per-MW revenue, the multiples compress into something more ordinary. If they fail to contract that capacity, the current valuation becomes hard to defend.
Catalysts to watch (2-5)
- Contract wins and commercial terms - announcements of multi-year leases, especially with non-crypto AI customers, would be a direct catalyst.
- Leasing pace toward the 1.5GW target - visible deployments and occupancy metrics will materially de-risk the growth story.
- Margin expansion in the hosting segment - as higher-margin colocation revenue replaces low-margin self-mining, adjusted EBITDA should improve.
- Refinancing or extension of the Morgan Stanley facility and any additional capital raises - favorable financing terms would lower refinancing risk.
- Industry power constraints - any re-rating in AI infrastructure names due to a power bottleneck could lift Core Scientific as a prime beneficiary.
Trade plan - actionable and time-defined
Trade direction: Long.
Entry price: $21.12.
Target price: $30.00.
Stop loss: $17.50.
Time horizon: long term (180 trading days) - I expect meaningful leasing traction, margin improvement and clearer guidance on capacity and contract structure to play out over several quarters; 180 trading days gives the company time to show tangible progress and the market time to re-rate fundamentals.
Rationale for levels: entry is near the current market price and recent support zone. Target of $30.00 is below the 52-week high of $30.46 but respects that the market has already priced some upside; reaching $30 requires either stronger-than-expected lease wins or visible margin improvement. A stop at $17.50 limits downside to the next structural support band and recognizes the company’s cash burn and financing sensitivity.
Risks - frank and prioritized
- Execution risk: Building and filling 1.5GW of leasable capacity is capital- and time-intensive. Delays, construction cost inflation, or slower-than-expected leasing would undermine the thesis.
- Capital structure and refinancing risk: Trailing free cash flow is deeply negative (roughly -$958M). The company is using near-term debt to fund expansion; adverse refinancing markets or covenant pressure could force dilutive equity raises or asset sales.
- Market concentration and customer risk: If a small number of customers fail to sign or renew, revenue visibility could deteriorate quickly. Long-term contracts are the antidote; absent them, cash flow remains volatile.
- Power and commodity price risk: While access to power is a moated advantage, electricity price spikes or transmission constraints could compress margins and reduce attractiveness to customers.
- Valuation risk: Current multiples embed significant future growth. Disappointment on growth or margins would likely result in material downside from current levels.
Counterarguments to the thesis
Critics will say Core Scientific is still a crypto relic with negative profitability and that converting a mining campus into an AI-grade colocation business is harder than management suggests. They point to Q4 revenue declines and continued adjusted losses as evidence that demand is not yet sustainable. Those are fair points - the company must prove it can book long-term, non-cyclical contracts to justify the valuation.
Another counterargument is capital intensity: scale requires cash, and continued negative free cash flow means shareholders face dilution risk if the company must issue equity to fund buildouts. That scenario would materially alter the risk-reward.
What would change my mind
I would significantly reduce conviction if the company fails to sign multi-year commitments for at least 25-35% of incremental capacity, or if refinancing conditions materially worsen and force dilutive equity issuance with poor terms. Conversely, multiple secured multi-year contracts with non-crypto AI customers or demonstrable margin expansion in hosting would increase the target and lower the perceived risk.
Conclusion
Core Scientific is a trade on transformation: from volatile mining rewards to predictable colocation revenue with a structural advantage - access to power and specialized facilities. The upside is meaningful if the company can sign long-duration leases, accelerate occupancy of its planned 1.5GW, and convert revenue into higher margins. The downside is real if execution stumbles, cash burn continues unabated, or refinancing conditions deteriorate.
For risk-tolerant traders who want exposure to an infrastructure play tied to AI and high-density compute, a disciplined long position at $21.12 with a stop at $17.50 and a target of $30.00 over the next 180 trading days is a pragmatic way to participate while protecting capital. Monitor leasing disclosures, contract durations and financing updates closely - those will be the clearest early indicators the story is becoming real.